Your shopping cart is empty

You are about to log out of

Would you like to place your order before you log out?

Log Out Continue Shopping

Prescribing Information

Before administering Adacel vaccine, please see full Prescribing Information.

Reimbursement Information

Adacel® (Tdap)

Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed  
For persons 10 through 64 years of age

Now available in a prefilled syringe made without natural rubber latex


Log in to order

About Adacel Vaccine



Adacel vaccine is contraindicated in persons who have had a severe allergic reaction (eg, anaphylaxis) to any other tetanus toxoid-, diphtheria toxoid-, or pertussis antigen-containing vaccine, or to any component of Adacel vaccine; or encephalopathy within 7 days after a previous dose of a pertussis antigen-containing vaccine with no other identifiable cause.

For one presentation of Adacel vaccine, the tip caps of the prefilled syringes may contain natural rubber latex, which may cause allergic reactions in latex-sensitive individuals. The vial stopper is not made with natural rubber latex.

If Guillain-Barré syndrome or brachial neuritis has occurred within 6 weeks following previous vaccination with a tetanus toxoid-containing vaccine, if progressive or unstable neurologic disorders exist, or if adverse events have occurred in temporal relation to receipt of pertussis antigen-containing vaccine, the decision to give Adacel vaccine should be based on careful consideration of the potential benefits and risks.

Persons who experienced an Arthus-type hypersensitivity reaction following a prior dose of tetanus toxoid-containing vaccine should not receive Adacel vaccine unless at least 10 years have elapsed since the last dose of tetanus toxoid-containing vaccine.

Syncope (fainting) can occur in association with administration of injectable vaccines, including Adacel vaccine. Procedures should be in place to prevent falling injury and manage syncopal reactions.

The most common local and systemic adverse reactions to Adacel vaccine include pain, erythema, and swelling at the injection site; headache, body ache or muscle weakness, and tiredness. Other adverse reactions may occur. Vaccination with Adacel vaccine may not protect all individuals.



Adacel vaccine is indicated for active booster immunization for the prevention of tetanus, diphtheria, and pertussis. Adacel vaccine is approved for use as a single dose in individuals 10 through 64 years of age.





Guides, Materials, & Brochures


Prescribing Information


Safety Data Sheet (SDS)

This website requires the use of cookies, but your web browser is not accepting them. Please enable cookies in order to use this site.